Hisun Pharmaceutical: Subsidiary obtains veterinary drug approval number for telmisartan oral solution

Hisun Pharmaceutical announced that its controlling subsidiary, Zhejiang Hisun Animal Health Products Co., Ltd., has received the veterinary drug product approval number approval document issued by the Ministry of Agriculture and Rural Affairs for telmisartan oral solution. The approval number is valid from October 8, 2026 to October 7, 2031. The product is used to treat proteinuria caused by chronic kidney disease in cats. This approval will enrich the company's product structure and promote the strategic layout of its pet medicine segment. There is uncertainty regarding the product's launch and sales.